Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology

Human Pathology

Volumn 40, Issue 7, 2009, Pages 924-933

  Fujita, Kazutoshi ^a   Pavlovich, Christian P ^a   Netto, George J ^a   Konishi, Yuko ^a   Isaacs, William B ^a   Ali, Syed ^a   De Marzo, Angelo ^a   Meeker, Alan K ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Biomarkers; Diagnosis; Multiplex staining; Prostate cancer; Urine cytology

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; 4' 6 DIAMIDINO 2 PHENYLINDOLE; NUCLEOLIN; TRANSCRIPTION FACTOR NKX3.1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CELL STRAIN LNCAP; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIGITAL RECTAL EXAMINATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE EPITHELIUM; SENSITIVITY AND SPECIFICITY; URINE CYTOLOGY;

ADULT; AGED; CELL LINE, TUMOR; CYTOLOGICAL TECHNIQUES; FALSE NEGATIVE REACTIONS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL; URINE;

EID: 67349257778     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.01.004     Document Type: Article

References (35)

1. Bologna M., Vicentini C., Festuccia C., et al. Early diagnosis of prostatic carcinoma based on in vitro culture of viable tumor cells harvested by prostatic massage. Eur Urol 14 (1988) 474-476
2. Garret M., and Jassie M. Cytologic examination of post prostatic massage specimens as an aid in diagnosis of carcinoma of the prostate. Acta Cytol 20 (1976) 126-131
3. Albers D.D., Mc D.J., and Thompson G.J. Carcinoma cells in prostatic secretions. J Am Med Assoc 139 (1949) 299-303
4. Guinan P., Gilham N., Nagubadi S.R., Bush I., Rhee H., and McKiel C. What is the best test to detect prostate cancer?. CA Cancer J Clin 31 (1981) 141-145
5. Sharifi R., Shaw M., Ray V., Rhee H., Nagubadi S., and Guinan P. Evaluation of cytologic techniques for diagnosis of prostate cancer. Urology 21 (1983) 417-420
6. Koss L.G., Deitch D., Ramanathan R., and Sherman A.B. Diagnostic value of cytology of voided urine. Acta Cytol 29 (1985) 810-816
7. Cairns P., Esteller M., Herman J.G., et al. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin Cancer Res 7 (2001) 2727-2730
8. Gonzalgo M.L., Pavlovich C.P., Lee S.M., and Nelson W.G. Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens. Clin Cancer Res 9 (2003) 2673-2677
9. Hessels D., Klein Gunnewiek J.M., van Oort I., et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 44 (2003) 8-15 [Discussion-6]
10. Laxman B., Tomlins S.A., Mehra R., et al. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. Neoplasia 8 (2006) 885-888
11. Rogers C.G., Yan G., Zha S., et al. Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein. J Urol 172 (2004) 1501-1503
12. Jeronimo C., Usadel H., Henrique R., et al. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer. Urology 60 (2002) 1131-1135
13. Tricoli J.V., Schoenfeldt M., and Conley B.A. Detection of prostate cancer and predicting progression: current and future diagnostic markers. Clin Cancer Res 10 (2004) 3943-3953
14. Smith A.M., Dave S., Nie S., True L., and Gao X. Multicolor quantum dots for molecular diagnostics of cancer. Expert Rev Mol Diagn 6 (2006) 231-244
15. Bethel C.R., Faith D., Li X., et al. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with Gleason score and chromosome 8p deletion. Cancer Res 66 (2006) 10683-10690
16. Wu Y.L., Dudognon C., Nguyen E., et al. Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths. J Cell Sci 119 (2006) 2797-2806
17. Papanicolaou G.N. A new procedure for staining vaginal smears. Science 95 (1942) 438-439
18. Djavan B., Zlotta A., Remzi M., et al. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. J Urol 163 (2000) 1144-1148 [discussion 8-9]
19. Keetch D.W., Catalona W.J., and Smith D.S. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 151 (1994) 1571-1574
20. Foot N.C., and Holmquist N.D. Supravita staining of sediments of serous effusions; a simple technique for rapid cytological diagnosis. Cancer 11 (1958) 151-157
21. Garret M., and Hamm F.C. Atypical cells of origin from the seminal vesicles, complicating cytologic evaluation of prostatic secretions. Am J Clin Pathol 39 (1963) 265-272
22. De Marzo A.M., DeWeese T.L., Platz E.A., et al. Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment. J Cell Biochem 91 (2004) 459-477
23. Luo J., Zha S., Gage W.R., et al. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 62 (2002) 2220-2226
24. Meeker A.K., Hicks J.L., Platz E.A., et al. Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res 62 (2002) 6405-6409
25. Rubin M.A., Zhou M., Dhanasekaran S.M., et al. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. Jama 287 (2002) 1662-1670
26. Tomlins S.A., Laxman B., Dhanasekaran S.M., et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448 (2007) 595-599
27. Nilsson M. Lock and roll: single-molecule genotyping in situ using padlock probes and rolling-circle amplification. Histochem Cell Biol 126 (2006) 159-164
28. Speel E.J., Hopman A.H., and Komminoth P. Tyramide signal amplification for DNA and mRNA in situ hybridization. Methods Mol Biol 326 (2006) 33-60
29. Schmitt F.C., Longatto-Filho A., Valent A., and Vielh P. Molecular techniques in cytopathology practice. J Clin Pathol 61 (2008) 258-267
30. Ali T.Z., Epstein J.I., Bieberich C.M., and De Marzo A.M. Nkx3.1 as a new tissue marker of prostatic adenocarcinoma. Mod Pathol 19 (2006) 128A
31. Kelemen P.R., Buschmann R.J., and Weisz-Carrington P. Nucleolar prominence as a diagnostic variable in prostatic carcinoma. Cancer 65 (1990) 1017-1020
32. Sturgis C.D., Box M., D'Costa R., Forgue B., McGuire M.S., and Dieterich M. Ancillary alpha-methylacyl-CoA racemase immunocytochemistry in the diagnosis of adenocarcinoma of the prostate in urinary cytology: a case report. Acta Cytol 50 (2006) 335-338
33. Vener T., Derecho C., Baden J., et al. Development of a multiplexed urine assay for prostate cancer diagnosis. Clin Chem 54 (2008) 874-882
34. Kern W.H., Bales C.E., and Webster W.W. Cytologic evaluation of transitional cell carcinoma of the bladder. J Urol 100 (1968) 616-622
35. Ntouroupi T.G., Ashraf S.Q., McGregor S.B., et al. Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope. Br J Cancer 99 (2008) 789-795